Halitus is a technology company.
Halitus has raised $1.0M across 1 funding round.
Halitus has raised $1.0M in total across 1 funding round.
Halitus has raised $1.0M in total across 1 funding round.
Halitus's investors include Better Ventures, Bjorn Kolbmuller, Dr. Cedric Duvinage, Julius Göllner, Mirko Caspar.
Halitus GmbH is a Berlin-based technology company developing non-invasive diagnostic tools that analyze exhaled breath to detect diseases through biomarkers.[1][2][3] It transforms complex medical sensor data, including the smallest molecules in breath, into actionable insights for healthcare applications like disease detection and precision medicine, serving patients and medical professionals.[1][5][6][7] The company operates at the intersection of health diagnostics, machine learning, and medical devices, with pre-seed funding of 1 million euros signaling early growth momentum in a nascent market.[3][5]
Halitus emerged from Berlin, Germany, as a startup focused on breath analysis technology, though specific founders and exact founding year are not detailed in available records.[3] The idea stems from advancing non-invasive diagnostics by detecting exhaled chemical biomarkers in real-time, building on sensor data processing and AI to interpret breath for bodily insights.[1][2][7] Early traction includes securing 1 million euros in pre-seed funding, highlighting pivotal validation from investors in health tech and machine learning sectors.[3][5]
Halitus rides the wave of AI-driven precision medicine and non-invasive diagnostics, capitalizing on trends in breathomics where exhaled molecules reveal metabolic and disease states.[2][6] Timing aligns with rising demand for quick, scalable health screening post-pandemic, fueled by advances in sensor tech and machine learning.[1][3] Market forces like aging populations and chronic disease prevalence favor breath-based tools for cost-effective early detection, positioning Halitus to influence healthcare by enabling point-of-care testing and reducing diagnostic burdens.[4][5][7]
Halitus is poised to scale its breath analytics platform through pilot evaluations and partnerships, potentially expanding to clinical trials and broader disease applications beyond initial biomarkers.[7] Trends like AI personalization in medtech and wearable integration will shape its path, amplifying non-invasive screening adoption.[6] Its influence may grow by setting standards in breathprinting, evolving from pre-seed innovator to key player in global health diagnostics—transforming breath into a vital health signal.[2][3]
Halitus has raised $1.0M across 1 funding round. Most recently, it raised $1.0M Seed in July 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2023 | $1.0M Seed | Better Ventures, Bjorn Kolbmuller, Dr. Cedric Duvinage, Julius Göllner, Mirko Caspar |